Chronic Hepatitis C Infection and Evolution of Treatment

Thursday, February 12, 2015 - 12:00pm to 12:45pm
Room Number: 
B111
Audience: 
College
Event Description: 

The first Coit Seminar of 2015 will feature Erik Mogalian, a senior clinical pharmacologist with Gilead Sciences, Inc. Mogalian holds both a PharmD and PhD from the College of Pharmacy. At Gilead, he helped develop new-generation medicines for hepatitis C. He will describe the development pathway of the medicines.

Lunch will be served. RSVP using the link below.

 

Contact Name: 
Barb Collins
PDF Attachment: 
Originally posted: January 9, 2015
Last updated: January 9, 2015
Want to update? Contact Webmaster
Share This